DE60109530D1 - Amorphe Mupirocin enthaltende Arzneimittel - Google Patents

Amorphe Mupirocin enthaltende Arzneimittel

Info

Publication number: DE60109530D1
Authority: DE; Germany
Prior art keywords: containing drugs; amorphous mupirocin; mupirocin containing; amorphous; drugs
Prior art date: 2000-07-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60109530T

Other languages

English (en)

Other versions

DE60109530T2 (de

Inventor

Ilana Lavon

Amira Zeevi

Stephen Cherkez

Moshe Arkin

Chalil Abu-Gnim

Yoav Raechav

Joseph Kaspi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Padagis Israel Pharmaceuticals Ltd

Original Assignee

Agis Industries 1983 Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2001-07-18

Publication date

2005-04-28

2001-07-18 Application filed by Agis Industries 1983 Ltd filed Critical Agis Industries 1983 Ltd

2005-04-28 Application granted granted Critical

2005-04-28 Publication of DE60109530D1 publication Critical patent/DE60109530D1/de

2006-02-09 Publication of DE60109530T2 publication Critical patent/DE60109530T2/de

2021-07-19 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
229960003128 mupirocin Drugs 0.000 title 1
229930187697 mupirocin Natural products 0.000 title 1
DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DE60109530T 2000-07-18 2001-07-18 Amorphe Mupirocin enthaltende Arzneimittel Expired - Fee Related DE60109530T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL13736300A IL137363A (en)	2000-07-18	2000-07-18	Pharmaceutical compositions containing mupirocin
IL13736300		2000-07-18

Publications (2)

Publication Number	Publication Date
DE60109530D1 true DE60109530D1 (de)	2005-04-28
DE60109530T2 DE60109530T2 (de)	2006-02-09

Family

ID=11074404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60109530T Expired - Fee Related DE60109530T2 (de)	2000-07-18	2001-07-18	Amorphe Mupirocin enthaltende Arzneimittel

Country Status (6)

Country	Link
US (1)	US6489358B2 (de)
EP (1)	EP1174133B1 (de)
CA (1)	CA2352915C (de)
DE (1)	DE60109530T2 (de)
ES (1)	ES2238393T3 (de)
IL (1)	IL137363A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200102234T2 (tr) *	1999-02-03	2002-10-21	Biogal Gyogyszergyar Rt.	Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem
CA2448547A1 (en)	2001-06-21	2003-01-03	Biogal Gyogyszergyar Rt.	Metabolic controlled fermentation process for pseudomonic acid production
KR20040075857A (ko) *	2001-12-28	2004-08-30	비오갈 기오기스제르갸르 알티.	결정질 및 비결정질 무피로신 칼슘의 제조 방법
IL150907A (en) *	2002-07-25	2007-07-04	Stephan Cherkez	Process for the preparation of stable amorphous calcium pseudomonate
JP2005536553A (ja) *	2002-08-21	2005-12-02	サイトキネティクス・インコーポレーテッド	化合物、組成物および方法
EP1619947A4 (de) *	2003-05-01	2006-05-31	Replidyne Inc	Antibakterielle verfahren und zusammensetzungen
US20050123576A1 (en) *	2003-12-03	2005-06-09	Ilana Lavon	Mupirocin compositions for topical use, an improved process of making same and methods of using same
WO2005117837A1 (en)	2004-06-01	2005-12-15	Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg	Process for preparation of amorphous form of a drug
JP5619352B2 (ja) *	2005-07-28	2014-11-05	バイオシネクサスインコーポレーティッド	細菌を処置するための組成物および方法
MXPA05009381A (es)	2005-09-02	2007-03-01	Fernando Ahumada Ayala	Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US7576054B2 (en) *	2005-10-11	2009-08-18	Biosynexus Incorporated	Compositions and methods for treating bacteria
WO2007130364A2 (en) *	2006-05-01	2007-11-15	Riolan Technologies, Inc.	Compositions, methods, and kits for treating dry eye
RU2585373C2 (ru)	2009-12-08	2016-05-27	Смит & Невью Ортопедикс АГ	Ферментная композиция и способ обработки ран
EP2444067A1 (de) *	2010-10-20	2012-04-25	Laboratorios Ojer Pharma S.L.	Wasserfreies Gel enthaltend Muciprocin
WO2016133471A1 (en)	2015-02-20	2016-08-25	Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş.	A topical composition comprising mupirocin and dexpanthenol
US11793783B2 (en)	2015-08-05	2023-10-24	Cmpd Licensing, Llc	Compositions and methods for treating an infection
US11446236B2 (en)	2015-08-05	2022-09-20	Cmpd Licensing, Llc	Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en)	2015-08-05	2023-06-27	Cmpd Licensing, Llc	Compositions and methods for treating an infection
SMT202400290T1 (it)	2019-10-24	2024-09-16	Vishagan Vanangamudi Sulur	Una composizione di mupirocina farmaceutica topica per infezioni batteriche e guarigione di ferita
CN110787128A (zh) *	2019-12-17	2020-02-14	福元药业有限公司	一种莫匹罗星软膏及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1196284A (en) *	1982-05-28	1985-11-05	Joshua Oduro-Yeboah	Pharmaceutical formulations
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
US4873012A (en) *	1986-10-29	1989-10-10	Colgate-Palmolive Company	Built nonaqueous liquid nonioinic laundry detergent composition containing hexylene glycol and method of use
JPH09506865A (ja) *	1993-10-22	1997-07-08	スミスクライン・ビーチャム・コーポレイション	新規組成物
CO4910145A1 (es) *	1996-10-01	2000-04-24	Smithkline Beecham Corp	Uso
IL123143A (en) *	1998-02-02	2001-08-26	Agis Ind 1983 Ltd	Pharmaceutical compositions containing mupirocin

2000
- 2000-07-18 IL IL13736300A patent/IL137363A/xx not_active IP Right Cessation
2001
- 2001-07-11 CA CA002352915A patent/CA2352915C/en not_active Expired - Fee Related
- 2001-07-18 US US09/906,828 patent/US6489358B2/en not_active Expired - Fee Related
- 2001-07-18 DE DE60109530T patent/DE60109530T2/de not_active Expired - Fee Related
- 2001-07-18 ES ES01306162T patent/ES2238393T3/es not_active Expired - Lifetime
- 2001-07-18 EP EP01306162A patent/EP1174133B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20020028843A1 (en)	2002-03-07
DE60109530T2 (de)	2006-02-09
CA2352915A1 (en)	2002-01-18
EP1174133A1 (de)	2002-01-23
US6489358B2 (en)	2002-12-03
IL137363A0 (en)	2001-07-24
EP1174133B1 (de)	2005-03-23
CA2352915C (en)	2008-09-23
ES2238393T3 (es)	2005-09-01
IL137363A (en)	2005-12-18

Publication	Publication Date	Title
DE60109530D1 (de)	2005-04-28	Amorphe Mupirocin enthaltende Arzneimittel
ATE311915T1 (de)	2005-12-15	Medikamentenspender
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
NO20030627D0 (no)	2003-02-07	Hydrogel-drevet medikament doseringsform
ATE318137T1 (de)	2006-03-15	Parenteral anzuwendendes bisphosphonathaltiges arzneimittel
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
ITMI991402A0 (it)	1999-06-24	Composti amorfi e relative composizioni farmaceutiche
IS6163A (is)	2001-11-16	Lyfjakomplex
EE200300045A (et)	2004-12-15	Kristalne ravimaine
DE50008261D1 (de)	2004-11-18	Retardierte darreichungsform enthaltend tramadolsaccharinat
NO20003030D0 (no)	2000-06-14	Flaskesmokk
UA4469S (uk)	2001-02-15	Упаковка для ліків
UA4808S (uk)	2001-05-15	Упаковка для ліків
UA4809S (uk)	2001-05-15	Упаковка для ліків
UA4807S (uk)	2001-05-15	Упаковка для ліків
UA4815S (uk)	2001-05-15	Упаковка для ліків
UA4806S (uk)	2001-05-15	Упаковка для ліків
NO20003408D0 (no)	2000-06-29	Tablettutleveringsanordning
UA4152S (uk)	2000-12-15	Пляшка сувенірна
CA89020S (fr)	2000-03-31	Bouteille
CA88796S (fr)	2000-02-25	Bouteille
ITMO20000202A0 (it)	2000-09-28	Contenitore igienico
UA4504S (uk)	2001-02-15	Пляшка
UA4262S (uk)	2000-12-15	Пляшка
UA4440S (uk)	2001-02-15	Пляшка

Legal Events

Date	Code	Title	Description
2006-05-11	8364	No opposition during term of opposition
2010-05-20	8339	Ceased/non-payment of the annual fee